Milestone Pharmaceuticals, Inc. (MIST)
0.9505
-0.03
(-3.02%)
USD |
NASDAQ |
Sep 14, 16:00
0.9505
0.00 (0.00%)
After-Hours: 17:01
Milestone Pharmaceuticals Price to Book Value : 6.496 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.698 |
| September 10, 2026 | 7.176 |
| September 09, 2026 | 7.312 |
| September 08, 2026 | 7.688 |
| September 04, 2026 | 8.201 |
| September 03, 2026 | 8.269 |
| September 02, 2026 | 8.064 |
| September 01, 2026 | 7.791 |
| August 31, 2026 | 7.927 |
| August 28, 2026 | 7.927 |
| August 27, 2026 | 8.132 |
| August 26, 2026 | 8.064 |
| August 25, 2026 | 7.927 |
| August 24, 2026 | 7.107 |
| August 21, 2026 | 7.210 |
| August 20, 2026 | 7.039 |
| August 19, 2026 | 7.381 |
| August 18, 2026 | 7.312 |
| August 17, 2026 | 7.517 |
| August 14, 2026 | 7.517 |
| August 13, 2026 | 7.312 |
| August 12, 2026 | 7.688 |
| August 11, 2026 | 8.679 |
| August 10, 2026 | 8.611 |
| August 07, 2026 | 8.337 |
| Date | Value |
|---|---|
| August 06, 2026 | 8.064 |
| August 05, 2026 | 7.825 |
| August 04, 2026 | 7.996 |
| August 03, 2026 | 7.654 |
| July 31, 2026 | 7.586 |
| July 30, 2026 | 7.859 |
| July 29, 2026 | 7.107 |
| July 28, 2026 | 7.312 |
| July 27, 2026 | 7.722 |
| July 24, 2026 | 7.927 |
| July 23, 2026 | 8.201 |
| July 22, 2026 | 8.132 |
| July 21, 2026 | 8.406 |
| July 20, 2026 | 8.064 |
| July 17, 2026 | 8.098 |
| July 16, 2026 | 8.474 |
| July 15, 2026 | 8.679 |
| July 14, 2026 | 8.884 |
| July 13, 2026 | 8.747 |
| July 10, 2026 | 8.747 |
| July 09, 2026 | 8.952 |
| July 08, 2026 | 8.337 |
| July 07, 2026 | 8.816 |
| July 06, 2026 | 9.021 |
| July 02, 2026 | 9.021 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 6.482 |
| NervGen Pharma Corp. | 19.14 |
| Clearmind Medicine, Inc. | 0.1524 |
| Lexaria Bioscience Corp. | 1.224 |
| Target Group, Inc. (Canada) | -- |
Price to Book Value Related Metrics
| PS Ratio | 47.84 |
| Price | 0.9505 |
| Earnings Yield | -72.99% |
| Market Cap | 118.34M |